A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

The next Alzheimer’s treatment could come from an unexpected place. In new research released this week, scientists have found ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

His geriatric doctor said "no" to prescribing medication to help slow down the disease. The doctor said his pulse rate is low ...

The geroscience hypothesis focuses on extending the healthy lifespan by targeting aging mechanisms. Recent advances in ...

University of Oklahoma's Dr. Sreemathi Logan leads a study on dementia, backed by a $2.2 million grant, focusing on aging, ...

Able to cross the blood-brain barrier, Xenon gas seemed to perk the mice right up, which began to become particularly active ...

A London clinic has become the first in Europe to roll out two Alzheimer’s wonder drugs privately after they were rejected ...